Prosperity can truly emerge when science-based researches meet economic feasibility and that is when contributing to the betterment of the world can be rewarded. By closing the gap between science and economy, Porteghal Accelerator can help turn your research into economic value and you projects to come to fruition.
Your Journey to the Future
Once a year, startups sign in for our acceleration program which starts in January and ends in December. After the selection process, 10 to 15 startups proceed to acceleration and post-acceleration phases in which they receive special mentoring and funding services during a 24 to 30 month period to exit as established companies.
Generva provides advanced conduits for peripheral nerve regeneration applicable for any damaged peripheral nerve region and nerve protectors for damaged nerve protection and tensionless repair.
BLOOCKAGE is a uniquely effective hemostatic agent in powder form used for treating arterial hemorrhage and different types of bleeding.
BIOPATCH produces a wide range of wound coverings (gels, films and patches) made of naturally-derived biopolymers.
IMMUNABLE is an immune system supplement that helps to strengthen the immune system against various diseases, especially cancer.
Amadge formulation is a targeted drug delivery system based on antibodies for controlling and/or treating HER2+ breast cancer in women.
Dara produces advanced hydropolymer wound care dressings fully compatible with the environment and human body.
Chitin, Chitosan, Glucosamine, and Pharmaceutical Salts
OsteoGen produces bone substitute pieces as replacements for the lost osseous tissue and bone granule and powder as bone void filler or augmentation material.
PAK Therapeutics develops and manufactures cancer multi-drug loaded in hydrophobic and hydrophilic modified biopolymer.